Collettini F, Hamm B
Klinik für Radiologie, Charité-Universitätsmedizin Berlin, Charitéplatz 1, Berlin, Deutschland.
Radiologe. 2011 Jul;51(7):589-95. doi: 10.1007/s00117-010-2119-1.
The treatment of uterine cervical carcinoma is largely dependent on the tumor stage. Despite significant inaccuracies in the clinical examination, uterine cervical cancer remains the only gynecological form of cancer still largely staged according to clinical findings. Although imaging is still not included in the staging the recently published revised FIGO (Fédération International de Gynécologie et d'Obstétrique) system encourages the use of modern cross-sectional imaging (magnetic resonance imaging MRI and computed tomography CT). Due to its high soft tissue contrast MRI allows excellent non-invasive assessment of the cervix with direct tumor delineation as well as assessment of the prognosis based on morphological factors. Studies in the literature report an accuracy of 93% for MRI in the preoperative assessment of tumor size and in the differentiation of operable from advanced cervical cancer. Therefore MRI is considered to be the optimal modality for diagnostic evaluation starting from FIGO stage IB1, for radiation therapy planning, and for exclusion of recurrence in follow-up. In this paper we give an overview of the role of magnetic resonance imaging in preoperative staging of uterine cervical cancer.
子宫颈癌的治疗很大程度上取决于肿瘤分期。尽管临床检查存在显著的不准确性,但子宫颈癌仍然是目前唯一主要依据临床检查结果进行分期的妇科癌症。虽然影像学检查仍未被纳入分期,但最近发布的修订版国际妇产科联盟(FIGO)系统鼓励使用现代横断面成像技术(磁共振成像MRI和计算机断层扫描CT)。由于MRI具有高软组织对比度,它能够对子宫颈进行出色的无创评估,直接勾勒肿瘤轮廓,并基于形态学因素评估预后。文献研究报告称,MRI在术前评估肿瘤大小以及区分可手术的子宫颈癌与晚期子宫颈癌方面的准确率为93%。因此,从FIGO 1B1期开始,MRI被认为是用于诊断评估、放射治疗计划制定以及随访中排除复发情况的最佳检查方式。在本文中,我们将概述磁共振成像在子宫颈癌术前分期中的作用。